• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Pharmaceuticals Portfolio

+ Add to Watchlist

FPHAX:US

21.11 USD 0.12 0.57%

As of 09:29:30 ET on 08/26/2014.

Snapshot for Fidelity Select Pharmaceuticals Portfolio (FPHAX)

Year To Date: +16.18% 3-Month: +5.29% 3-Year: +27.26% 52-Week Range: 15.82 - 21.35
1-Month: +1.59% 1-Year: +32.62% 5-Year: +22.60% Beta vs MXWO: 0.88

Mutual Fund Chart for FPHAX

No chart data available.
  • FPHAX:US 21.11
  • 1M
  • 1Y
Interactive FPHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FPHAX

Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.

Inception Date: 06-18-2001 Telephone: 1-800-544-6666
Managers: ASHER ANOLIC
Web Site: www.fidelity.com

Fundamentals for FPHAX

NAV (on 2014-08-26) 21.11
Assets (M) (on 2014-07-31) 1,517.30
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FPHAX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-04-11) 0.35
Dividend Yield (ttm) 12.97

Fees & Expenses for FPHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.81

Top Fund Holdings for FPHAX

Filing Date: 06/30/2014
Name Position Value % of Total
AbbVie Inc 2,039,490 115,108,816 6.641%
Actavis plc 491,820 109,700,451 6.329%
Novartis AG 1,033,898 93,598,786 5.400%
AstraZeneca PLC 1,256,200 93,348,222 5.385%
Johnson & Johnson 886,100 92,703,782 5.348%
Merck & Co Inc 1,560,536 90,277,008 5.208%
Bristol-Myers Squibb Co 1,611,410 78,169,499 4.510%
Shire PLC 310,800 73,190,292 4.222%
Perrigo Co PLC 472,452 68,864,604 3.973%
Valeant Pharmaceuticals Intern 515,527 65,193,958 3.761%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil